ES8608535A1 - Procedimiento para preparar una composicion para el tratamiento topico de acne - Google Patents

Procedimiento para preparar una composicion para el tratamiento topico de acne

Info

Publication number
ES8608535A1
ES8608535A1 ES535711A ES535711A ES8608535A1 ES 8608535 A1 ES8608535 A1 ES 8608535A1 ES 535711 A ES535711 A ES 535711A ES 535711 A ES535711 A ES 535711A ES 8608535 A1 ES8608535 A1 ES 8608535A1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
composition
acne
ether
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535711A
Other languages
English (en)
Other versions
ES535711A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16435683A external-priority patent/JPS6056921A/ja
Priority claimed from JP15700984A external-priority patent/JPS6136219A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES535711A0 publication Critical patent/ES535711A0/es
Publication of ES8608535A1 publication Critical patent/ES8608535A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE UNA COMPOSICION CONTRA EL ACNE. COMPRENDE: A) DISOLVER UN 0,001% A 2% DE UN COMPUESTO DE FORMULA (I) EN UN 5-70% DE ETANOL O BENZOL; B) AÑADIR UN 0,001 A 20% DE UN POLIMERO CARBOXIVINILICO COMO AGENTE GELIFICANTE, UN 0,001 A 15% DE UN AGENTE QUERATOLITICO, COMO UREA, RESORCINOL, ACIDO SALICILICO, PEROXIDO DE BENZOILO, Y COMPLETAR EL 100% CON AGUA O UN DEPRESOR DE SECRECION DE SEBO O UN ANTIMICROBIANO Y OTROS; C) AJUSTAR EL PH DE LA COMPOSICION OBTENIDA ENTRE 4 Y 8 CON UN ACIDO TAL COMO EL CLORHIDRICO O CITRICO, CON UNA BASE, COMO SOSA, POTASA TRIETANOLAMINA O DIISO-PROPANOLAMINA. SIENDO LA LINEA DISCONTINUA UN DOBLE ENLACE INSATURADO. SE UTILIZA EN FARMACOLOGIA PARA EL TRATAMIENTO TOPICO DE LAS INFLAMACIONES CRONICAS DE LAS GLANDULAS PILOSEBACEAS.
ES535711A 1983-09-07 1984-09-06 Procedimiento para preparar una composicion para el tratamiento topico de acne Expired ES8608535A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16435683A JPS6056921A (ja) 1983-09-07 1983-09-07 皮膚外用剤
JP15700984A JPS6136219A (ja) 1984-07-27 1984-07-27 皮膚外用剤

Publications (2)

Publication Number Publication Date
ES535711A0 ES535711A0 (es) 1986-06-16
ES8608535A1 true ES8608535A1 (es) 1986-06-16

Family

ID=26484601

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535711A Expired ES8608535A1 (es) 1983-09-07 1984-09-06 Procedimiento para preparar una composicion para el tratamiento topico de acne

Country Status (6)

Country Link
US (1) US4657901A (es)
EP (1) EP0138029B1 (es)
AU (1) AU570998B2 (es)
DE (1) DE3485408D1 (es)
ES (1) ES8608535A1 (es)
GR (1) GR80293B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110801A (en) * 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
EP0516026A1 (en) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel and method of producing same
JP2937667B2 (ja) * 1992-11-19 1999-08-23 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5624915A (en) * 1993-08-04 1997-04-29 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
JPH09501936A (ja) * 1993-08-26 1997-02-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 生物活性ペプチドをコードする裸のポリヌクレオチドを投与するための方法、組成物および装置
US20080213378A1 (en) * 1998-10-01 2008-09-04 Elan Pharma International, Ltd. Nanoparticulate statin formulations and novel statin combinations
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US8236352B2 (en) * 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
EP2266542A3 (en) * 1998-10-01 2013-07-31 Elan Pharma International Limited Controlled release nanoparticulate compositions
US6969529B2 (en) * 2000-09-21 2005-11-29 Elan Pharma International Ltd. Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
US20040141925A1 (en) * 1998-11-12 2004-07-22 Elan Pharma International Ltd. Novel triamcinolone compositions
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7998507B2 (en) * 2000-09-21 2011-08-16 Elan Pharma International Ltd. Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
US7198795B2 (en) * 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US20030064084A1 (en) * 2001-09-24 2003-04-03 Bradley Pharmaceuticals, Inc. Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
ATE464880T1 (de) * 2002-02-04 2010-05-15 Elan Pharma Int Ltd Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator
US20040101566A1 (en) * 2002-02-04 2004-05-27 Elan Pharma International Limited Novel benzoyl peroxide compositions
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents
US20050272819A1 (en) * 2003-07-31 2005-12-08 Arye Rubinstein Use of alkylureas for treating acne
GB0505909D0 (en) * 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2900575B1 (fr) * 2006-05-05 2008-10-17 Anteis Sa Gel biocompatible a liberation controlee, son procede de preparation et son utilisation
US20090258865A1 (en) 2008-03-28 2009-10-15 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
US10548862B2 (en) * 2017-12-29 2020-02-04 Lester J. Wu Topical formulation and method for preventing or treating acne

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions

Also Published As

Publication number Publication date
EP0138029B1 (en) 1992-01-02
AU570998B2 (en) 1988-03-31
EP0138029A2 (en) 1985-04-24
US4657901A (en) 1987-04-14
ES535711A0 (es) 1986-06-16
DE3485408D1 (de) 1992-02-13
GR80293B (en) 1985-01-08
EP0138029A3 (en) 1988-06-29
AU3243484A (en) 1985-03-14

Similar Documents

Publication Publication Date Title
ES8608535A1 (es) Procedimiento para preparar una composicion para el tratamiento topico de acne
MX9701538A (es) Sales de un derivado del indol contra la migraña.
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
ES8706664A1 (es) Procedimiento para preparar compuestos carbostirilicos
JO1704B1 (en) New potent compounds
NZ216048A (en) Quinolylglycinamide derivatives, and pharmaceutical compositions containing such
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
AU546158B2 (en) Cycloaliphatic pharmaceutical compounds
IL124431A0 (en) Sulfur containing dl-tert-butylphenol compounds useful as anti-inflammatory agents
JPS55162777A (en) 11*naphthyllnnpropyl*imidazole derivative* its manufacture and medicinal composition containing same
MY137475A (en) Chemical compounds.
IT8348031A0 (it) Composizione farmaceutica contenente un composto di 1,4-benzochinone e suo impiego come agente antifibro tico
AU578295B2 (en) Phenyl-substituted naphthyridines and their use as anti-ulcer drugs
IL112110A0 (en) Octahydro-1h-isoindoles and pharmaceutical compositions containing them
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
ES8205219A1 (es) Un metodo para producir un compuesto de hidrouracilo
GR3030731T3 (en) Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them
ES8308562A1 (es) Procedimiento para preparar 3',4',5'-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas
CS127484A2 (en) Zpusob vyroby n ( trifluormethylfenyl) n propargylpipera zinu
ES8307252A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido clavulanico.
ES2000369A6 (es) Un procedimiento para preparar di-t-butilfenoles sustituidos
ZA811585B (en) Anti-inflammatory compositions
ES8206544A1 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas
ES2027507A6 (es) Procedimiento de preparacion de derivados selenofenicos.
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis